03-Apr-2008 - The use of disposable manufacturing equipment in pharmaceutical production and greater need for containment equipment were recurring themes at the Interphex show in Philadelphia last week, and both were addressed by new equipment from Bosch Packaging Technology.
30-Mar-2008 - IntelliPharmaCeutics is ready to move into full-scale clinical trials with a once-daily oral formulation of oxycodone based on the company's ReXista abuse- and alcohol-resistant technology.
27-Mar-2008 - New research has shown that the FDA's strict 10-month deadline for a drug's approval following submission may compromise drug safety and lead to insufficient data for precise drug administration.
27-Mar-2008 - The ageing population of the European Union (EU) could result in a stagnation in technological innovation, according to a new report. As science and technology professionals get older and less socially mobile, there are fears that it could result in a loss in scientific expertise.
27-Mar-2008 - Research and development investment by America's pharmaceutical and biotechnology research companies reached a record $58.8bn last year, a rise of $3bn since 2006.
26-Mar-2008 - Drug regulator Health Canada has published its draft guidelines for pharmaceutical firms seeking to gain approval for biosimilars or "subsequent entry biologics."
26-Mar-2008 - The generic pharmaceutical industry has given short shrift to the latest congressional attempt to construct a viable approval pathway for biosimilars in the US.
26-Mar-2008 - Redpoint Bio has been issued with a patent for an assay technology which tests whether a compound enhances or inhibits the bitter or sweet taste of different ingredients, allowing the company to screen for flavour enchancing compounds.
26-Mar-2008 - The pharmaceutical industry has lost confidence in the UK as a place to do business to an "alarming degree" and the situation is only set to deteriorate, reveals new research.
17-Mar-2008 - The costs of introducing any formal good manufacturing practice (GMP) requirements for potentially high-risk pharmaceutical excipients in the European Union would far exceed the likely benefits, concludes an impact assessment for the European Commission.
11-Mar-2008 - Drug delivery specialist Eurand could see a marked increase in revenue flow this year, both from co-development products incorporating the company's formulation technologies and a proprietary treatment addressing the estimated $720m worldwide market for exocrine pancreatic insufficiency (EPI).
06-Mar-2008 - A joint development partnership between Malvern Instruments and imaging specialist FEI has produced what the companies claim is the first ever tool for determining the size and shape of sub-micron particles through direct analysis.
21-Feb-2008 - Germany's rap.ID Particle Systems has launched a new lab-ready particle identification device capable of identifying around 400 particles an hour from 5µm and up. The company says the device is suited for development and quality assurance in the pharmaceutical industry.
07-Feb-2008 - Germany put in a strong showing as category winners were announced for the fourth annual Facility of the Year Awards (FOYA) recognising innovation in pharmaceutical manufacturing projects.
07-Feb-2008 - Russian scientists have created a device that determines micro- and nano-particle size using a laser technology that claims to be more accurate than methods currently used in the laboratory and could find a role in pharmaceutical quality control.
30-Jan-2008 - A non-destructive method of carrying out a series of tests on solid dosage forms, developed by UK firm Teraview, can be carried out in real time on the production line and could be used in continuous processing systems, according to a new study.
29-Jan-2008 - Unexpected contract downturns have resulted in Catalent Pharma Solutions having to lay off 100 workers at its soft gelatin capsules facility in St Petersburg, Florida.
22-Jan-2008 - Bristol-Myers Squibb (BMS) has revealed plans to close another site in Puerto Rico in its latest cost-cutting move.
22-Jan-2008 - Novartis has announced the US approval of its first-in-class blood pressure med Tekturna (aliskiren) combined with a diuretic in a single-tablet formulation.
10-Jan-2008 - BioAlliance Pharma has gained marketing authorisation for its novel muco-adhesive antifungal tablet in the UK and Denmark, triggering a €2.5m payment and marching on with the drug's launch across Europe.
08-Jan-2008 - A starch-based film coating for nutraceuticals which can be tailored to manufacturer's needs is being developed through a strategic partnership by Roquette and Biogrund.
03-Jan-2008 - Despite a two month extension of the PDUFA date by the US Food and Drug Administration (FDA), Sciele and SkyePharma this week announced the approval of their controlled release formulation of high blood pressure drug Sular (nisoldipine).
02-Jan-2008 - Italy's Fine Foods has purchased a domestic contract manufacturer operating in the pharmaceutical arena, extending its presence in this industry.
17-Dec-2007 - Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology.
17-Dec-2007 - Patheon has finally revealed its plans to tackle the ongoing problems it has been facing with its Puerto Rican operations, which are draining the firm of profitability.